Home / Market News / $LONN

$LONN news and market catalysts

The 3 most recent market catalysts affecting $LONN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 1 high impact 2 bullish 0 bearish Pharmaceuticals
Nov 12, 2026 Corporate Catalyst Neutral Impact 55
Alnylam Executive Bertha Steinmetz Vilela to Depart for Lonza
Alnylam Pharmaceuticals is losing its head of international human resources, Bertha Steinmetz Vilela, who is moving to Lonza as their new Chief Human Resources Officer. This is a r…
Nov 4, 2026 Corporate Catalyst Bullish Impact 65
RBC Raises Lonza Price Target to 820 CHF
RBC has raised its price target for Lonza to 820 CHF from 760 CHF after Lonza's acquisition of five sites from Merck. This matters because the analysts view the deal as having favo…
Nov 3, 2026 Corporate Catalyst Bullish Impact 92
Lonza to Acquire CDMO Business from Merck KGaA
Lonza has announced a definitive agreement to acquire the CDMO (Contract Development and Manufacturing Organization) business from Merck KGaA's Life Science sector. This acquisitio…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.